Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke

NCT00123305 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke, Acute

Interventions

DRUG: Microplasmin
DRUG: Microplasmin

Sponsor

ThromboGenics